Tomasello S (2008) Secondary hyperparathyroidism and chronic kidney disease. Diabetes Spectr 21:19–25. https://doi.org/10.2337/diaspect.21.1.19

Article  Google Scholar 

Salem MM (1997) Hyperparathyroidism in the hemodialysis population: a survey of 612 patients. Am J Kidney Dis 29:862–865. https://doi.org/10.1016/S0272-6386(97)90459-5

Article  CAS  PubMed  Google Scholar 

Xu Y, Evans M, Soro M et al (2021) Secondary hyperparathyroidism and adverse health outcomes in adults with chronic kidney disease. Clin Kidney J 14:2213–2220. https://doi.org/10.1093/ckj/sfab006

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kovesdy CP, Ahmadzadeh S, Anderson JE, Kalantar-Zadeh K (2008) Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease. Kidney Int 73:1296–1302. https://doi.org/10.1038/ki.2008.64

Article  CAS  PubMed  Google Scholar 

Khan S (2007) secondary hyperparathyroidism is associated with higher cost of care among chronic kidney disease patients with cardiovascular comorbidities. Nephron Clin Pract 105:c159–c164. https://doi.org/10.1159/000099006

Article  PubMed  Google Scholar 

Joy MS, Karagiannis PC, Peyerl FW (2007) Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment. J Manag Care Pharm 13:397–411. https://doi.org/10.18553/jmcp.2007.13.5.397

Galassi A, Ciceri P, Fasulo E et al (2019) Management of secondary hyperparathyroidism in chronic kidney disease: a focus on the elderly. Drugs Aging 36:885–895. https://doi.org/10.1007/s40266-019-00696-3

Article  CAS  PubMed  Google Scholar 

Slatopolsky E, Brown A, Dusso A (2001) Role of phosphorus in the pathogenesis of secondary hyperparathyroidism. Am J Kidney Dis 37:S54–S57. https://doi.org/10.1053/ajkd.2001.20740

Article  CAS  PubMed  Google Scholar 

Barreto FC, Barreto DV, Massy ZA, Drüeke TB (2019) Strategies for phosphate control in patients With CKD. Kidney Int Rep 4:1043–1056. https://doi.org/10.1016/j.ekir.2019.06.002

Article  PubMed  PubMed Central  Google Scholar 

Gutzwiller J, Schneditz D, Huber AR et al (2002) Estimating phosphate removal in haemodialysis: an additional tool to quantify dialysis dose. Nephrol Dial Transplant 17:1037–1044. https://doi.org/10.1093/ndt/17.6.1037

Article  CAS  PubMed  Google Scholar 

Daugirdas JT (2022) Comparison of measured vs kinetic-model predicted phosphate removal during hemodialysis and hemodiafiltration. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc 37:2522–2527. https://doi.org/10.1093/ndt/gfac223

Article  CAS  Google Scholar 

Elias RM, Alvares VRC, Moysés RMA (2018) Phosphate removal during conventional hemodialysis: a decades-old misconception. Kidney Blood Press Res 43:110–114. https://doi.org/10.1159/000487108

Article  CAS  PubMed  Google Scholar 

Debowska M, Dai L, Wojcik-Zaluska A et al (2020) Association between biomarkers of mineral and bone metabolism and removal of calcium and phosphate in hemodialysis. Blood Purif 49:71–78. https://doi.org/10.1159/000503623

Article  CAS  PubMed  Google Scholar 

https://www.crea.gov.it/-/tabella-di-composizione-degli-alimenti

Hruska KA, Mathew S, Lund R et al (2008) Hyperphosphatemia of chronic kidney disease. Kidney Int 74:148–157. https://doi.org/10.1038/ki.2008.130

Article  CAS  PubMed  PubMed Central  Google Scholar 

Isakova T, Wahl P, Vargas GS et al (2011) Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 79:1370–1378. https://doi.org/10.1038/ki.2011.47

Article  CAS  PubMed  PubMed Central  Google Scholar 

Block GA, Hulbert-Shearon TE, Levin NW, Port FK (1998) Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis Off J Natl Kidney Found 31:607–617. https://doi.org/10.1053/ajkd.1998.v31.pm9531176

Article  CAS  Google Scholar 

Kestenbaum B, Sampson JN, Rudser KD et al (2005) Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol JASN 16:520–528. https://doi.org/10.1681/ASN.2004070602

Article  CAS  PubMed  Google Scholar 

Shanahan CM, Crouthamel MH, Kapustin A, Giachelli CM (2011) Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res 109:697–711. https://doi.org/10.1161/CIRCRESAHA.110.234914

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martínez-Moreno JM, Herencia C, de Oca AM et al (1979) High phosphate induces a pro-inflammatory response by vascular smooth muscle cells and modulation by vitamin D derivatives. Clin Sci Lond Engl 131:1449–1463. https://doi.org/10.1042/CS20160807

Article  CAS  Google Scholar 

Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group (2017) KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 7:1–59

Article  Google Scholar 

Ramirez JA, Emmett M, White MG et al (1986) The absorption of dietary phosphorus and calcium in hemodialysis patients. Kidney Int 30:753–759. https://doi.org/10.1038/ki.1986.252

Article  CAS  PubMed  Google Scholar 

Gotch FA, Panlilio F, Sergeyeva O et al (2003) A kinetic model of inorganic phosphorus mass balance in hemodialysis therapy. Blood Purif 21:51–57. https://doi.org/10.1159/000067866

Article  CAS  PubMed  Google Scholar 

Daugirdas JT, Chertow GM, Larive B et al (2012) Effects of frequent hemodialysis on measures of CKD mineral and bone disorder. J Am Soc Nephrol JASN 23:727–738. https://doi.org/10.1681/ASN.2011070688

Article  CAS  PubMed  Google Scholar 

Man NK, Chauveau P, Kuno T et al (1991) Phosphate removal during hemodialysis, hemodiafiltration, and hemofiltration. A reappraisal. ASAIO Trans 37:M463-465

CAS  PubMed  Google Scholar 

DeSoi CA, Umans JG (1993) Phosphate kinetics during high-flux hemodialysis. J Am Soc Nephrol JASN 4:1214–1218. https://doi.org/10.1681/ASN.V451214

Article  CAS  PubMed  Google Scholar 

Pierratos A, Ouwendyk M, Francoeur R et al (1998) Nocturnal hemodialysis: three-year experience. J Am Soc Nephrol JASN 9:859–868. https://doi.org/10.1681/ASN.V95859

Article  CAS  PubMed  Google Scholar 

Mucsi I, Hercz G, Uldall R et al (1998) Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int 53:1399–1404. https://doi.org/10.1046/j.1523-1755.1998.00875.x

Article  CAS  PubMed  Google Scholar 

Block G, Do TP, Collins AJ et al (2016) Co-trending of parathyroid hormone and phosphate in patients receiving hemodialysis. Clin Nephrol 85:142–151. https://doi.org/10.5414/CN108629

Article  CAS  PubMed  Google Scholar 

Minutolo R, Bellizzi V, Cioffi M et al (2002) Postdialytic rebound of serum phosphorus: pathogenetic and clinical insights. J Am Soc Nephrol JASN 13:1046–1054. https://doi.org/10.1681/ASN.V1341046

Article  CAS  PubMed  Google Scholar